trial · primary record
2 mL SunButyrate-TG
Congenital Heart Disease (CHD)
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 105 |
| Primary completion | 2029-12-31 |
| Primary endpoint | Combined Incidence of Adverse Events and Serious Adverse Events with Butyric Acid (SunButyrate-TG) Supplementation |
| Registry ID | NCT06882772 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:47.403Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06882772
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.